# Diabetic Foot Osteomyelitis Treatment Using Gentamicin-loaded Calcium Sulfate-hydroxyapatite Biocomposite

> **NCT05316298** · — · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 182 (estimated)

## Conditions studied

- Diabetic Foot Ulcer
- Osteomyelitis
- Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05316298
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2022-11-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316298, "Diabetic Foot Osteomyelitis Treatment Using Gentamicin-loaded Calcium Sulfate-hydroxyapatite Biocomposite". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05316298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*